{"id":882003,"date":"2025-09-04T10:01:12","date_gmt":"2025-09-04T14:01:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\/"},"modified":"2025-09-04T10:01:12","modified_gmt":"2025-09-04T14:01:12","slug":"autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\/","title":{"rendered":"Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor \u201cWhat This Means\u201d Segment"},"content":{"rendered":"
\n

\n Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discusses the Company\u2019s recently announced results from the post hoc analysis of its proof-of-concept human clinical trial (\u201cPoC 1\u201d)<\/em>
\n \n <\/p>\n

\n THE WOODLANDS, TX, Sept. 04, 2025 (GLOBE NEWSWIRE) — <\/strong>
\n Autonomix Medical, Inc.<\/a> (NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced the release of a Virtual Investor \u201cWhat This Means\u201d segment<\/a>.<\/p>\n

For the segment, Dr. Robert Schwartz, Chief Medical Officer<\/a> of Autonomix, discussed the Company\u2019s recently announced longer-term post hoc analysis results from its proof-of-concept human clinical trial (\u201cPoC 1\u201d) which demonstrated sustained pain reduction, quality of life gains and 100% zero opioid use.<\/p>\n

The \u201cWhat This Means\u201d segment can be accessed here<\/a>.<\/p>\n

\n About Autonomix Medical, Inc.<\/strong>\n <\/p>\n

Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company\u2019s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.<\/p>\n

We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States.<\/p>\n

For more information, visit autonomix.com<\/a> and connect with the Company on X<\/a>, LinkedIn<\/a>, Instagram<\/a> and Facebook<\/a>.<\/p>\n

\n Investor and Media Contact<\/strong>\n <\/p>\n

JTC Team, LLC
Jenene Thomas
908.824.0775
autonomix@jtcir.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discusses the Company\u2019s recently announced results from the post hoc analysis of its proof-of-concept human clinical trial (\u201cPoC 1\u201d) THE WOODLANDS, TX, Sept. 04, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced the release of a Virtual Investor \u201cWhat This Means\u201d segment. For the segment, Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discussed the Company\u2019s recently announced longer-term post hoc analysis results from its proof-of-concept human clinical trial (\u201cPoC 1\u201d) which demonstrated sustained pain reduction, quality of life gains and 100% zero opioid … <\/p>\n

Continue reading “Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor \u201cWhat This Means\u201d Segment”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-882003","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAutonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor \u201cWhat This Means\u201d Segment - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor \u201cWhat This Means\u201d Segment - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discusses the Company\u2019s recently announced results from the post hoc analysis of its proof-of-concept human clinical trial (\u201cPoC 1\u201d) THE WOODLANDS, TX, Sept. 04, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced the release of a Virtual Investor \u201cWhat This Means\u201d segment. For the segment, Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discussed the Company\u2019s recently announced longer-term post hoc analysis results from its proof-of-concept human clinical trial (\u201cPoC 1\u201d) which demonstrated sustained pain reduction, quality of life gains and 100% zero opioid … Continue reading "Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor \u201cWhat This Means\u201d Segment"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-04T14:01:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMzI4MSM3MTMwMzU5IzUwMDExOTk5Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor \u201cWhat This Means\u201d Segment\",\"datePublished\":\"2025-09-04T14:01:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\\\/\"},\"wordCount\":321,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyMzI4MSM3MTMwMzU5IzUwMDExOTk5Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\\\/\",\"name\":\"Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor \u201cWhat This Means\u201d Segment - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyMzI4MSM3MTMwMzU5IzUwMDExOTk5Mg==\",\"datePublished\":\"2025-09-04T14:01:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyMzI4MSM3MTMwMzU5IzUwMDExOTk5Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUyMzI4MSM3MTMwMzU5IzUwMDExOTk5Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor \u201cWhat This Means\u201d Segment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor \u201cWhat This Means\u201d Segment - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\/","og_locale":"en_US","og_type":"article","og_title":"Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor \u201cWhat This Means\u201d Segment - Market Newsdesk","og_description":"Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discusses the Company\u2019s recently announced results from the post hoc analysis of its proof-of-concept human clinical trial (\u201cPoC 1\u201d) THE WOODLANDS, TX, Sept. 04, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (\u201cAutonomix\u201d or the \u201cCompany\u201d), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced the release of a Virtual Investor \u201cWhat This Means\u201d segment. For the segment, Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discussed the Company\u2019s recently announced longer-term post hoc analysis results from its proof-of-concept human clinical trial (\u201cPoC 1\u201d) which demonstrated sustained pain reduction, quality of life gains and 100% zero opioid … Continue reading \"Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor \u201cWhat This Means\u201d Segment\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\/","og_site_name":"Market Newsdesk","article_published_time":"2025-09-04T14:01:12+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMzI4MSM3MTMwMzU5IzUwMDExOTk5Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor \u201cWhat This Means\u201d Segment","datePublished":"2025-09-04T14:01:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\/"},"wordCount":321,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMzI4MSM3MTMwMzU5IzUwMDExOTk5Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\/","name":"Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor \u201cWhat This Means\u201d Segment - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMzI4MSM3MTMwMzU5IzUwMDExOTk5Mg==","datePublished":"2025-09-04T14:01:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMzI4MSM3MTMwMzU5IzUwMDExOTk5Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUyMzI4MSM3MTMwMzU5IzUwMDExOTk5Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/autonomix-medical-inc-nasdaq-amix-participates-in-virtual-investor-what-this-means-segment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor \u201cWhat This Means\u201d Segment"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/882003","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=882003"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/882003\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=882003"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=882003"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=882003"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}